<DOC>
	<DOC>NCT00214578</DOC>
	<brief_summary>The purpose of this study is to determine whether six months treatment with the antipsychotic medicine Seroquel (quetiapine) may affect the schizophrenic patient's glucose metabolism</brief_summary>
	<brief_title>Seroquel on Glucose Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>In or outpatients with schizophrenia, 1865 years old, requiring a change in treatment due to insufficient efficacy or tolerability and giving signed informed consent. Known diabetes mellitus, high HbA1c, fasting plasma glucose and/or high 2h glucoseOGTT. Previous use of atypicals (3 months) or other medications that might influence glucose metabolism Contraindications or nonresponsiveness for any of the treatments or other safety issues Expected noncompliance to treatment and/or study procedures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>